Biotech Growth Trust (The) (LSE:BIOG) 5-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:BIOG Biotech Growth Trust (The) PLC LSE:BIOG
30 GF Score
Price £16.04
! 4 Warning Signs
View Full Analysis

What is Biotech Growth Trust (The) 5-Year EBITDA Growth Rate?

Biotech Growth Trust (The) LSE:BIOG -1.84% 30 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates LSE:BIOG with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

Biotech Growth Trust (The)'s EBITDA per Share for the six months ended in Mar. 2026 was £2.89.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Biotech Growth Trust (The)  (LSE:BIOG) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Biotech Growth Trust (The) 5-Year EBITDA Growth Rate Related Terms

LSE:BIOG vs BLK, BX, KKR: 5-Year EBITDA Growth Rate Comparison

For the Asset Management subindustry, Biotech Growth Trust (The)'s 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Growth Trust (The) 5-Year EBITDA Growth Rate vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s 5-Year EBITDA Growth Rate falls into.


LSE:BIOG
30GF Score
Biotech Growth Trust (The) PLC LSE:BIOG
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotech Growth Trust (The) 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Biotech Growth Trust (The) (LSE:BIOG) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Biotech Growth Trust (The) and its competitors.
Is Biotech Growth Trust (The)'s 5-Year EBITDA Growth Rate too high?
Biotech Growth Trust (The)'s current 5-Year EBITDA Growth Rate is 0.00%. Overall, Biotech Growth Trust (The) has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Biotech Growth Trust (The)'s 5-Year EBITDA Growth Rate compare to BLK and BX?
Biotech Growth Trust (The)'s 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for an Asset Management company?
A good 5-Year EBITDA Growth Rate depends on the Asset Management industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Biotech Growth Trust (The) and its competitors. Biotech Growth Trust (The)'s current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotech Growth Trust (The) stock overvalued right now?
Biotech Growth Trust (The) (LSE:BIOG) has a current 5-Year EBITDA Growth Rate of 0.00%. The current 5-Year EBITDA Growth Rate is 0.00%. Biotech Growth Trust (The)'s overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Biotech Growth Trust (The) (LSE:BIOG), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotech Growth Trust (The) Business Description

Address 25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is an externally managed investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world.
30GF Score

Get the complete analysis for LSE:BIOG

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£16.04
Price